Setchanova Lena Petrova, Kostyanev Tomislav, Markovska Rumyana, Miloshev George, Mitov Ivan Gergov
Department of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria.
Scand J Infect Dis. 2013 Feb;45(2):81-7. doi: 10.3109/00365548.2012.710854. Epub 2012 Sep 19.
To determine the serotypes, antimicrobial susceptibility, and beta-lactam resistance mechanisms of Haemophilus influenzae strains isolated from invasive and respiratory tract infections (RTIs) prior to the introduction of Haemophilus influenzae type b (Hib) vaccination in Bulgaria.
A total of 259 isolates were serotyped by polymerase chain reaction. Susceptibility to antibiotics and beta-lactamase production were determined, and DNA sequencing of the ftsI gene was performed for ampicillin non-susceptible strains.
The invasive H. influenzae infections in children were mainly due to serotype b (94.5% in meningitis and 88.9% in other invasive cases). Non-typeable strains (97.4%) were the most frequently found H. influenzae strains in RTIs both in children and adults. Non-susceptibility to ampicillin occurred in 22% of all strains. Ceftriaxone and levofloxacin were the most active agents tested. Ampicillin resistance occurred in 34.4% of invasive strains, and beta-lactamase production was the only mechanism found. Among respiratory tract isolates, ampicillin non-susceptible strains (18%) were classified into the following groups: beta-lactamase-positive, ampicillin-resistant (BLPAR) strains (7.2%); beta-lactamase-negative, ampicillin-non-susceptible (BLNAR) strains (8.2%); and beta- lactamase-positive, amoxicillin-clavulanate-resistant (BLPACR) strains (2.6%). Among 21 BLNAR and BLPACR strains there were 9 different patterns of multiple-amino acid substitutions in penicillin-binding protein 3. Of these, most isolates (81.0%) belonged to group II, defined by the Asn526Lys substitution.
Beta-lactamase production was more common among invasive strains than in respiratory isolates. BLNAR and BLPACR H. influenzae were found only among respiratory tract isolates.
确定在保加利亚引入b型流感嗜血杆菌(Hib)疫苗接种之前,从侵袭性感染和呼吸道感染(RTIs)中分离出的流感嗜血杆菌菌株的血清型、抗菌药敏性及β-内酰胺耐药机制。
采用聚合酶链反应对总共259株分离菌株进行血清分型。测定其对抗生素的敏感性及β-内酰胺酶的产生情况,并对氨苄西林不敏感菌株进行ftsI基因的DNA测序。
儿童侵袭性流感嗜血杆菌感染主要由b型血清型引起(脑膜炎中占94.5%,其他侵袭性病例中占88.9%)。不可分型菌株(97.4%)是儿童和成人RTIs中最常见的流感嗜血杆菌菌株。所有菌株中22%对氨苄西林不敏感。头孢曲松和左氧氟沙星是测试中活性最强的药物。34.4%的侵袭性菌株对氨苄西林耐药,且仅发现β-内酰胺酶产生是耐药机制。在呼吸道分离菌株中,氨苄西林不敏感菌株(18%)分为以下几类:β-内酰胺酶阳性、氨苄西林耐药(BLPAR)菌株(7.2%);β-内酰胺酶阴性、氨苄西林不敏感(BLNAR)菌株(8.2%);以及β-内酰胺酶阳性、阿莫西林-克拉维酸耐药(BLPACR)菌株(2.6%)。在21株BLNAR和BLPACR菌株中,青霉素结合蛋白3存在9种不同的多氨基酸替代模式。其中,大多数分离菌株(81.0%)属于由Asn526Lys替代定义的II组。
β-内酰胺酶产生在侵袭性菌株中比在呼吸道分离菌株中更常见。BLNAR和BLPACR流感嗜血杆菌仅在呼吸道分离菌株中发现。